CCIA
STJ

Campbell & Co Investment Adviser’s St Jude Medical STJ Stock Holding History

Campbell & Co Investment Adviser’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,812
Closed -$240K – 333
2015
Q3 		$240K Buy
+3,812
New +$272K 0.16% 229
2014
Q2 		– Sell
-5,100
Closed -$333K – 287
2014
Q1 		$333K Buy
+5,100
New +$332K 0.13% 156

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Campbell & Co Investment Adviser's STJ Position: Q4 2015 in Review

Campbell & Co Investment Adviser sold out of St Jude Medical (STJ) in Q4 2015, closing a stake of 3,812 shares — an estimated $240K sold.

Campbell & Co Investment Adviser first reported a position in STJ in Q1 2014 and held it in 2 quarters. The position peaked at $333K in Q1 2014. 620 funds tracked by Wall St. Rank hold STJ as of Q4 2015.

  • Campbell & Co Investment Adviser reported no remaining St Jude Medical position as of Q4 2015 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 3,812 St Jude Medical shares in Q4 2015, an estimated $240K.
  • Campbell & Co Investment Adviser first reported a position in St Jude Medical in Q1 2014 and held it in 2 quarters.
  • Campbell & Co Investment Adviser's St Jude Medical position peaked at $333K in Q1 2014.
  • 620 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2015.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2015, filed 16 Feb 2016.